Nexgenia Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and cell separations for diagnostic and life science applications. Its magnetic nanoparticles perform cell separation on different cell types. Nexgenias technology is based on unique and proprietary families of stimuli-responsive smart polymers that change their state in response to small, discrete changes in their environment. The company serves diagnostic, pharmaceutical and biotech companies. Nexgenia is headquartered in Seattle, Washington, the US.

Nexgenia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nexgenia Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nexgenia Raises USD0.12 Million in Venture Financing 10
Nexgenia Raises USD1.8 Million in Venture Financing 11
Nexgenia Raises USD1.6 Million in Financing Round 12
Nexgenia Raises USD0.5 Million in Seed Financing Round 13
Partnerships 14
Nexgenia Enters into Co-Development Agreement with Seattle Childrens Research Institute 14
Licensing Agreements 15
Nexgenia Enters into Licensing Agreement with CSIRO 15
Nexgenia Enters into Licensing Agreement with University of Washington 16
Nexgenia Inc - Key Competitors 17
Nexgenia Inc - Key Employees 18
Nexgenia Inc - Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Nexgenia Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nexgenia Raises USD0.12 Million in Venture Financing 10
Nexgenia Raises USD1.8 Million in Venture Financing 11
Nexgenia Raises USD1.6 Million in Financing Round 12
Nexgenia Raises USD0.5 Million in Seed Financing Round 13
Nexgenia Enters into Co-Development Agreement with Seattle Childrens Research Institute 14
Nexgenia Enters into Licensing Agreement with CSIRO 15
Nexgenia Enters into Licensing Agreement with University of Washington 16
Nexgenia Inc, Key Competitors 17
Nexgenia Inc, Key Employees 18

List Of Figures


Nexgenia Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Nexgenia Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and

USD 250 View Report

Nexgenia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company provides stimuli-responsive polymers and polymer-containing magnetic nanoparticles that improves the speed, efficiency, and sensitivity of molecular

USD 250 View Report

Bioverativ Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant

USD 250 View Report

AOL Inc - Strategic SWOT Analysis Review

AOL Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available